Cancer News: Cervical
In a phase 2 trial, a targeted antitumor drug prolonged survival for women with cervical cancer which has spread to the nearby tissues or lymph nodes.
An FDA committee unanimously recommended to replace the Pap smear by a human papillomavirus (HPV) test as the 1st-line standard for cervical cancer screening.
Young women treated with radiation for cervical cancer have increased risk of colorectal cancer. Therefore, they should begin screening earlier than normal.
A new type of personalized immunotherapy ("adoptive T cell therapy") showed striking results in a small phase 2 study for women with advanced cervical cancer.